Journal of Vascular and Interventional Radiology Increases Impact, Offers New Initiatives

Society of Interventional Radiology's Flagship Publication Ranks Highest of All Interventional Radiology Journals, According to Thomson Reuters' Journal Citation Reports®

FAIRFAX, Va., Aug. 2, 2011 /PRNewswire-USNewswire/ -- The Journal of Vascular and Interventional Radiology's impact factor—the measure of a journal's "impact" (or significance) based on the number of article citations compared to the total number of articles published—increased nearly 15 percent in 2010. While the journal's quality and influence has remained consistently high over the past five years, the journal's core strengths have been enhanced recently by the increased use of new media (such as podcasts), a reconfigured internationally focused editorial board and an average time-to-first decision of under 30 days for new manuscripts.

(Logo: http://photos.prnewswire.com/prnh/20100127/SIRLOGO)

"The Journal of Vascular and Interventional Radiology's increased ranking reflects the journal's unflagging commitment to quality and tradition of excellence, showing it as an essential resource for interventional radiologists, radiologists, cardiologists, vascular surgeons, neurosurgeons and other clinicians across the United States and the world who need current and reliable information on every aspect of vascular and interventional radiology," said editor in chief Ziv J Haskal, M.D., FSIR. "JVIR is the highest ranked interventional radiology journal in the world. It continues to be the vigorous forum for the most novel and impactful, global, cutting-edge, basic science research, clinical reports and evidence-based medicine. JVIR science can truly provide patients with the best possible health care," he added. "Always innovative, JVIR is providing rapid, tight reviewing and early decision—giving authors visibility for their research and readers increased access to more information through multiple new channels," said Haskal. "These results confirm JVIR's position as a lead destination for research in peripheral vascular and venous disease, oncology, women's health and all other aspects of endovascular therapy," noted the professor of radiology and surgery at the University of Maryland School of Medicine and vice chair of strategic development and chief of vascular and interventional radiology, image-guided therapy and interventional oncology at the University of Maryland Medical Center, both in Baltimore, Md.

JVIR—the monthly, peer-reviewed flagship publication of the Society of Interventional Radiology—earned an impact factor of 2.064, an increase from 1.805 in 2009, according to new data released in the 2010 Journal Citation Reports® published by Thomson Reuters. JVIR ranks higher than other prominent journals in the radiology, nuclear medicine and medical imaging category, such as CardioVascular and Interventional Radiology (CVIR). The impact factor is often used as a measure of the quality and influence of medical journals within scientific, professional and academic communities. JVIR published 275 articles in 2010, earning 5,900 citations among radiology, nuclear medicine and medical imaging journals and peripheral vascular disease journals.

The journal's continued excellence is the result of the efforts of the current editorial board—renowned reviewers from around the globe who ensure uniformity, fairness and efficiency in manuscript handling, comments and revisions—as well as Albert A. Nemcek Jr., M.D., FSIR, the journal's previous editor, and previous editorial board members, said Haskal. "JVIR's efforts continue to highlight the global impact of this minimally invasive specialty and its lead journal," he added.

The journal has further expanded the ways in which it delivers news of the specialty with the new JVIR podcast channel, providing short, hard-hitting interviews that provide insight into methodology, controversy and next directions for research, said Haskal. JVIR's Web site has been redesigned and includes many new features, such as improved navigation; access to current articles, features and issues; and the most up-to-date information on research and other interventional radiology news. JVIR podcasts are also available on SIR's Web site (www.SIRweb.org).

The Journal of Vascular and Interventional Radiology is available online at www.JVIR.org. A yearly subscription to the journal is $454 for individuals and $641 for institutions. Other countries (prices include airspeed delivery): individual $483, institutions $662. A free journal subscription is a benefit of SIR membership. More information about the Society of Interventional Radiology and the Journal of Vascular and Interventional Radiology can be found online at www.SIRweb.org.

About the Society of Interventional Radiology
Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit www.SIRweb.org.

SOURCE Society of Interventional Radiology